Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effective ReperfusiOn Strategy for Patients With ST-segment Elevation Myocardial Infarction Guided by Optical Coherence Tomography Versus ANgiography (EROSION III): a Multicenter, Randomized Controlled Trial

NCT03571269 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT03571269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03571269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effective ReperfusiOn Strategy for Patients With ST-segment Elevation Myocardial Infarction Guided by Optical Coherence Tomography Versus ANgiography (EROSION III): a Multicenter, Randomized Controlled Trial
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Completed
Start date
December 21, 2017
Completion date
December 24, 2020
Enrollment
246 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

st-segment elevation myocardial infarction